Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 1 Patrick D. Guinan, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502. Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 2 Malika Haque, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505. Case and Commentary May 2005 End of Life and Sanctity of Life, Commentary 3 Lerwut Wongsarnpigoon, MD Virtual Mentor. 2005;7(5):342-351. doi: 10.1001/virtualmentor.2005.7.5.ccas2-0505. Case and Commentary Sep 2007 Pregnant Women and Cervical Cancer: Balancing Best Interest of Mother and Fetus Watson A. Bowes, Jr., MD Virtual Mentor. 2007;9(9):600-604. doi: 10.1001/virtualmentor.2007.9.9.ccas1-0709. Case and Commentary Oct 2009 The Patient Who Says He Is Ready to Die Margaret Tarpley, MLS and John Tarpley, MD Virtual Mentor. 2009;11(10):761-765. doi: 10.1001/virtualmentor.2009.11.10.ccas3-0910. Case and Commentary Sep 2004 Reproductive Rights, Commentary 1 Watson A. Bowes Jr., MD Virtual Mentor. 2004;6(9):387-389. doi: 10.1001/virtualmentor.2004.6.9.ccas2-0409. Case and Commentary Sep 2004 Reproductive Rights, Commentary 2 Karen E. Adams, MD and Martin T. Donohoe, MD Virtual Mentor. 2004;6(9):389-391. doi: 10.1001/virtualmentor.2004.6.9.ccas2-0409. Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 1 Patrick D. Guinan, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 1 Ludger Schols, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary Feb 2005 Quality of Life and Prenatal Decisions, Commentary 2 Georg Marckmann, MD Virtual Mentor. 2005;7(2):136-140. doi: 10.1001/virtualmentor.2005.7.2.ccas1-0502.
Case and Commentary May 2005 Patau Syndrome and Perinatal Decision Making, Commentary 2 Malika Haque, MD Virtual Mentor. 2005;7(5):336-341. doi: 10.1001/virtualmentor.2005.7.5.ccas1-0505.
Case and Commentary May 2005 End of Life and Sanctity of Life, Commentary 3 Lerwut Wongsarnpigoon, MD Virtual Mentor. 2005;7(5):342-351. doi: 10.1001/virtualmentor.2005.7.5.ccas2-0505.
Case and Commentary Sep 2007 Pregnant Women and Cervical Cancer: Balancing Best Interest of Mother and Fetus Watson A. Bowes, Jr., MD Virtual Mentor. 2007;9(9):600-604. doi: 10.1001/virtualmentor.2007.9.9.ccas1-0709.
Case and Commentary Oct 2009 The Patient Who Says He Is Ready to Die Margaret Tarpley, MLS and John Tarpley, MD Virtual Mentor. 2009;11(10):761-765. doi: 10.1001/virtualmentor.2009.11.10.ccas3-0910.
Case and Commentary Sep 2004 Reproductive Rights, Commentary 1 Watson A. Bowes Jr., MD Virtual Mentor. 2004;6(9):387-389. doi: 10.1001/virtualmentor.2004.6.9.ccas2-0409.
Case and Commentary Sep 2004 Reproductive Rights, Commentary 2 Karen E. Adams, MD and Martin T. Donohoe, MD Virtual Mentor. 2004;6(9):389-391. doi: 10.1001/virtualmentor.2004.6.9.ccas2-0409.
Viewpoint Apr 2014 Inappropriate Obstructions to Access: The FDA’s Handling of Plan B Susan F. Wood, PhD The FDA’s approval for over-the-counter sales of emergency contraception marked a departure from its standard approval process and obstructed access to a safe and effective drug. That departure could set a dangerous precedent for future decisions. Virtual Mentor. 2014;16(4):295-301. doi: 10.1001/virtualmentor.2014.16.4.oped1-1404.